Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines

European Journal of Cancer

Volumn 37, Issue 5, 2001, Pages 629-640

  Perez, M ^a   Migliaccio, S ^a,b   Taranta, A ^a   Festuccia, C ^b   Orru L ^b   Brama, M ^b   Bologna, M ^b   Faraggiana, T ^a,c   Baron, R ^d,e   Teti, A ^b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c SANOFI   (France)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bone metastasis; c Src; Cytokine; Melanoma; Osteoblast; Osteoclast; Osteoclastogenesis

Indexed keywords

COLECALCIFEROL; COLONY STIMULATING FACTOR 1; CYTOKINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE RELATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CELL CONTACT; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; MELANOMA B16; MELANOMA CELL; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; ONCOGENE SRC; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STROMA CELL; TIME;

ANIMALS; BONE RESORPTION; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, SRC; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; OSTEOBLASTS; OSTEOCLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0035094315     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00436-6     Document Type: Article

References (49)

1. Malignant melanoma: Death by image and ignorance, diagnosis by surgical excision and laboratory investigation
2. General mechanisms of metastasis
3. The prevalence and location of metastases from ocular melanoma: Imaging study in 110 patients
4. Mechanisms of bone metastasis
5. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone
6. Hypercalcemia and maligant melanoma
7. Regulation of osteoclast function
8. Bone formation: Osteoblast lineage cells, growth factors, matrix proteins, and the mineralization process
9. Factors regulating the growth of metastatic cancer in bone
10. Advances in bone biology: The osteoclast
11. A murine model of experimental metastasis to bone and bone marrow
12. A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells: Application to the characterization of serum response element binding proteins during osteoclast differentiation
13. Tartronates: A new generation of drugs affecting bone metabolism
14. Single step method of RNA isolated by acid guanidinium thiocyanate-phenol-chloroform extraction
15. Expression of parathyroid hormone-related protein in cells of osteoblast lineage
16. Expression of colony-stimulating factor-1 in vivo during the formation of osteoclasts
17. Ovarian immune cells express granulocyte-macrophage colony-stimulating factor (GM-CSF) during follicular growth and luteinization in gonadotropin-primed immature rodents
18. Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair
19. Rapid induction of cytokine and e-selectin expression in the liver in response to metastatic tumor cells
20. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cutlures: Correlation with osteoclast-like cell formation
21. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture
22. Osteoclast isolation: New developments and methods
23. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis
24. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity
25. Serum interleukin-6 levels correlate to tumour progression and prognosis in metastatic breast carcinoma
26. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
27. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo
28. Breast cancer cells interact with osteoblasts to support osteoclast formation
29. Control of osteoclast differentiation
30. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
31. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
32. Human breast cancer induces osteoclast actrivation and increases the numbers of osteoclasts at sites of tumor osteolyisis
33. Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells
34. Mouse mammary carcinoma cell line (BALB/c-MC) stimulates osteoclast formation from mouse bone marrow cells through cell-to-cell contact
35. Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts
36. Morphology of bone metastasis
37. Use of bisphosphonates for the treatment of bone metastasis in experimental animal models
38. Inhibitory effects of bisphosphonate (YM175) on bone resorption induced by a metastatic bone tumour
39. TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF
40. Tumour necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
41. The role of IL-6 type cytokines and their receptors in bone
42. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro
43. Identification of a novel neuronal c-src exon expressed in human brain
44. Blood platelets express high levels of pp60src-specific tyrosine kinase activity
45. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts
46. Decreased c-Src expression enhances osteoblast differentiation and bone formation
47. Tyrosine kinase Src inhibtirors mechanisms of action in potential therapeutic applications
48. Bone resorption induced by a metastatic human melanoma cell line
49. Bisphosphonates and breast carcinoma